HIV

HIV Prevention Drug to Become Affordable in Nigeria and 119 Other Countries

by

Gilead Sciences has announced plans to provide affordable versions of its innovative HIV prevention drug, lenacapavir, in 120 low and middle-income countries. Administered as a twice-yearly injection, lenacapavir has demonstrated significant effectiveness in clinical trials, leading to a notable reduction in HIV infection rates among both women and men. Trials conducted in South Africa and … Read more

NACA Allegedly Claims That Individuals Living with HIV/AIDS Face Increased Risk of Contracting Monkeypox.

by

The National Agency for the Control of AIDS (NACA) has issued an important advisory for people living with HIV/AIDS (PLWH) as Mpox (formerly known as Monkeypox) continues to spread both within the country and across the continent. NACA emphasizes that individuals with weakened immune systems are at a heightened risk of severe complications from Mpox. … Read more